Market Overview

Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound Care with the Related Surgical Procedure into Two-Tier System

Share:

Osiris
Therapeutics (NASDAQ: OSIR) announced today that, on November 27, 2013, the
Centers for Medicare and Medicaid Services (CMS) released their proposed
ruling for the reimbursement of skin substitutes in the hospital
outpatient setting. CMS decided to package the reimbursement for
products used in advanced wound care with the related surgical procedure
into a two-tier system.

The proposed ruling means that the current payment methodology for Grafix®
will not immediately be impacted by the changes described in the
proposed ruling. Grafix will maintain its current transitional
pass-through status and that

See full press release

Posted-In: News Guidance Contracts Management Global

 

Related Articles (OSIR)

View Comments and Join the Discussion!